Remove Governance Remove Medical Billing Remove Medicare Remove Prescription Drug Pricing
article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ million expansion ‘Very, very unusual.’

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

The 55 hospitals penalized by Medicare 8 years straight over patient complications. CMS overhauls Direct Contracting model to include new requirements on governance, health equity in 2023. Medicare penalizes 40 hospitals in Florida for patient safety. Whitmer signs bills designed to lower prescription drug prices in Michigan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

in billing fraud Arizona system names new CEO Banner Health CEO Peter Fine to retire after 24 years, handing the reins to health system president Four UArizona bioscience startups selected for Flinn Foundation program Gov. s health, hospital chief says Raising Ky.’s

article thumbnail

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Health Populi

The year-on-year decline from 2021 find oil and gas at the lowest level of positivity, advertising/PR, legal, the Federal government, and pharma at the bottom of the ratings. Peoples’ highest ratings of industry in American occurred in 2017 when nearly 50% of people gave business a very or somewhat positive grade.

article thumbnail

The 2020 Health Populi TrendCast – HealthConsuming, TechLash, and Public Health Goes Private

Health Populi

With the emergence of six-to-seven figure specialty drugs coming out of the Rx pipeline into commerce, we can expect growing financial toxicity as a side effect of these therapies, and evolving financial services offered to patients to pay, say, on an installment plan as Bluebird Therapeutics has offered (specifically, $1.78